about
Early Upregulation of Acute Respiratory Distress Syndrome-Associated Cytokines Promotes Lethal Disease in an Aged-Mouse Model of Severe Acute Respiratory Syndrome Coronavirus InfectionYeast based small molecule screen for inhibitors of SARS-CoVBat and virusCynomolgus macaque as an animal model for severe acute respiratory syndrome.SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection.Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirusCoronavirus antibodies in African bat speciesRecombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.Comparative pathogenesis of three human and zoonotic SARS-CoV strains in cynomolgus macaquesMechanisms of severe acute respiratory syndrome pathogenesis and innate immunomodulation.De novo identification of viral pathogens from cell culture hologenomes.Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection.Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003.Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice.Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective.An animal model that reflects human disease: the common marmoset (Callithrix jacchus).Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challengeSevere acute respiratory syndrome-coronavirus infection in aged nonhuman primates is associated with modulated pulmonary and systemic immune responses.Middle East respiratory syndrome coronavirus (MERS-CoV): evidence and speculations.Pathogenesis of Middle East respiratory syndrome coronavirus.MAVS-mediated apoptosis and its inhibition by viral proteins.A highly conserved WDYPKCDRA epitope in the RNA directed RNA polymerase of human coronaviruses can be used as epitope-based universal vaccine design.The SARS-coronavirus nsp7+nsp8 complex is a unique multimeric RNA polymerase capable of both de novo initiation and primer extension.Emerging infectious diseases: opportunities at the human-animal-environment interface.Truly emerging--a new disease caused by a novel virus.Effectiveness of Masks and Respirators Against Respiratory Infections in Healthcare Workers: A Systematic Review and Meta-Analysis.The temporal distribution of new H7N9 avian influenza infections based on laboratory-confirmed cases in Mainland China, 2013-2017.Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
P2860
Q27488870-F90EF09F-78E0-4B5F-9387-0449ACFE9EABQ28478245-38BE1496-9C10-4357-9639-B357105B0091Q28602415-A794C506-6626-4FAB-B1D7-807C0392036FQ33239453-39078A65-A1F8-415E-9865-0F567D04CA77Q33553351-C1986D61-059A-4DB1-9512-6D9BED29CC80Q33614444-7C0ED556-F17C-4854-9C65-ED5619651A1EQ33678943-3948B3F8-9EEB-47C2-BBE6-F2406F0FEC55Q33800892-BFC9FC89-9CA4-414E-A16E-C557DEB490E0Q33834543-FF144D05-D3E6-4EAE-8110-846BA02A0C62Q33886371-BB69C19C-02D6-42A9-B892-52F0D4DC52E7Q34014960-F683A972-CECC-4009-94C9-CBC7819EBA97Q34120899-2EEB38DF-9501-441F-A7D9-7D649C8CAA68Q34190597-4DB6C4FC-2766-4DC6-8F25-9010A974EF00Q34430859-0E205236-BA7A-47C9-BA35-E939879A752BQ35914462-3B281DC0-2B9E-4D72-A0D2-61ADB16D940DQ36029845-ECE6C680-C281-46CF-9529-F90796F0B404Q36045238-4A542371-C7EA-4F18-891D-E59FB9B92F9DQ36498144-0291F3E1-0EA0-4827-8E74-44BC6400C1A4Q37723794-C1648B90-8EFE-4001-A84C-E9E1E59DA4B1Q38187028-8B20F02C-D5CA-4D61-BF90-9D67DB43CCC7Q38258027-60E6A13B-34BB-4E45-B5CC-62DA8CDD04E0Q39858569-22465668-04A2-452B-9817-BAD8297F73B5Q40179727-EB7A3144-4037-4084-B4B2-BDADB64C20FBQ41578444-BBFED0D5-D2B0-498D-8E26-76557C661B71Q42210888-716CA801-BC0A-4A8D-B549-F06427649A37Q42933930-F70DCA51-637E-4967-B355-DE9DE3C8B958Q47579628-4D2BB229-BD78-48DA-8698-DBEC2D938289Q52671080-653B6675-FC71-4175-8FDE-098E1F44AD61Q53704198-4587AEE2-7297-415E-92AB-0F25523F1F8A
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
SARS: epidemiology.
@ast
SARS: epidemiology.
@en
SARS: epidemiology.
@nl
type
label
SARS: epidemiology.
@ast
SARS: epidemiology.
@en
SARS: epidemiology.
@nl
prefLabel
SARS: epidemiology.
@ast
SARS: epidemiology.
@en
SARS: epidemiology.
@nl
P2860
P1433
P1476
SARS: epidemiology.
@en
P2093
Moira Chan-Yeung
Rui-Heng Xu
P2860
P356
10.1046/J.1440-1843.2003.00518.X
P478
P577
2003-11-01T00:00:00Z